Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Oncology (Williston Park, N.Y.)
|
December 18, 2016
Amitkumar Mehta on the Immunomodulating Effects of Targeted Therapy for Multiple Myeloma
Amitkumar Mehta
Blood
|
July 8, 2014
Disseminated fusariosis during acute myelogenous leukemia induction treatment
Amitkumar Mehta, Naresh Bellam
Expert Review of Hematology
|
September 8, 2015
Novel agents for the treatment of Hodgkin lymphoma
Komal Dumaswala, Amitkumar Mehta
Expert Review of Hematology
|
January 18, 2017
Treatment approaches of hard-to-treat non-Hodgkin lymphomas
Lakshminarayanan Nandagopal, Amitkumar Mehta
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
September 19, 2018
Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy
Joanna Zurko, Amitkumar Mehta
CNS Oncology
|
July 24, 2014
Current advances in understanding and managing secondary brain metastasis
Radhika Dasararaju, Amitkumar Mehta
Expert Review of Hematology
|
January 26, 2016
Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy
Muhammad O Jamil, Amitkumar Mehta
Current Oncology Reports
|
July 22, 2015
Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin Lymphoma
Amitkumar Mehta, Andres Forero-Torres
Current Treatment Options in Oncology
|
December 17, 2013
How do I recommend extended adjuvant hormonal therapy?
Amitkumar Mehta, John T Carpenter
Expert Review of Hematology
|
June 11, 2019
A review of chimeric antigen receptor T-cells in lymphoma
Jennifer Kelly Anderson, Amitkumar Mehta
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Oncology (Williston Park, N.Y.)
|
December 18, 2016
Amitkumar Mehta on the Immunomodulating Effects of Targeted Therapy for Multiple Myeloma
Amitkumar Mehta
Blood
|
July 8, 2014
Disseminated fusariosis during acute myelogenous leukemia induction treatment
Amitkumar Mehta, Naresh Bellam
Expert Review of Hematology
|
September 8, 2015
Novel agents for the treatment of Hodgkin lymphoma
Komal Dumaswala, Amitkumar Mehta
Expert Review of Hematology
|
January 18, 2017
Treatment approaches of hard-to-treat non-Hodgkin lymphomas
Lakshminarayanan Nandagopal, Amitkumar Mehta
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
September 19, 2018
Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy
Joanna Zurko, Amitkumar Mehta
CNS Oncology
|
July 24, 2014
Current advances in understanding and managing secondary brain metastasis
Radhika Dasararaju, Amitkumar Mehta
Expert Review of Hematology
|
January 26, 2016
Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy
Muhammad O Jamil, Amitkumar Mehta
Current Oncology Reports
|
July 22, 2015
Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin Lymphoma
Amitkumar Mehta, Andres Forero-Torres
Current Treatment Options in Oncology
|
December 17, 2013
How do I recommend extended adjuvant hormonal therapy?
Amitkumar Mehta, John T Carpenter
Expert Review of Hematology
|
June 11, 2019
A review of chimeric antigen receptor T-cells in lymphoma
Jennifer Kelly Anderson, Amitkumar Mehta
Page
of 8